Since Akt activation plays a central role in tonic BCR signaling, and rescues BCR knock-out in B-cell lymphoma cell lines [66], these genetic alterations may replace the function of BCR signaling among neoplastic cells in CHLs lacking BCR expression [67]. This evidence concerns the gene BCR and B-cell non-Hodgkin lymphoma.